Search Results - "McNicholl, Adrian G"
-
1
Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies
Published in Helicobacter (Cambridge, Mass.) (01-08-2017)“…Background As with any other infectious disease, we should aim for treatments offering ≥90% Helicobacter pylori eradication rates in clinical practice. Aim To…”
Get full text
Journal Article -
2
Meta‐analysis of three‐in‐one single capsule bismuth‐containing quadruple therapy for the eradication of Helicobacter pylori
Published in Helicobacter (Cambridge, Mass.) (01-04-2019)“…Background Bismuth‐containing quadruple therapy has been suggested as first‐line and rescue alternative for Helicobacter pylori eradication. Our objective was…”
Get full text
Journal Article -
3
Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse
Published in Inflammatory bowel diseases (01-08-2009)“…Background: The purpose of the study was to determine the role of fecal calprotectin and lactoferrin in the prediction of inflammatory bowel disease relapses,…”
Get full text
Journal Article -
4
A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication)
Published in Expert opinion on pharmacotherapy (01-05-2013)“…Helicobacter pylori infection is generally treated with therapies that include a proton pump inhibitor (PPI) and, at least, two antibiotics being…”
Get more information
Journal Article -
5
Accuracy of GastroPanel for the diagnosis of atrophic gastritis
Published in European journal of gastroenterology & hepatology (01-09-2014)“…BACKGROUNDIt has been suggested that GastroPanel might be a useful tool for the diagnosis of chronic atrophic gastritis (CAG) measuring four biomarkers in…”
Get full text
Journal Article -
6
Helicobacter pylori treatment results in Slovenia in the period 2013-2015 as a part of European Registry on Helicobacter pylori Management
Published in Radiology and oncology (01-03-2018)“…is the most common chronic bacterial infection in the world affecting over 50% of the world's population. is a grade I carcinogen, responsible for the…”
Get full text
Journal Article -
7
Protocol of the European Registry on the management of Helicobacter pylori infection (Hp‐EuReg)
Published in Helicobacter (Cambridge, Mass.) (01-10-2019)“…Introduction Helicobacter pylori selectively infects the human stomach, being the most prevalent chronic infection in the world. H pylori presence causes…”
Get full text
Journal Article -
8
Research to the N-Power: The Strengths of Networked Clinical Collaboration in Spain
Published in The American journal of gastroenterology (01-12-2017)Get full text
Journal Article -
9
Sequential versus standard triple first-line therapy for Helicobacter pylori eradication
Published in Cochrane database of systematic reviews (28-06-2016)“…Non-bismuth quadruple sequential therapy (SEQ) comprising a first induction phase with a dual regimen of amoxicillin and a proton pump inhibitor (PPI) for five…”
Get more information
Journal Article -
10
Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients
Published in Clinical gastroenterology and hepatology (01-01-2020)“…Due to the poor eradication rates of standard triple therapy, the addition of bismuth salts has been proposed for first-line eradication of Helicobacter…”
Get full text
Journal Article -
11
A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma
Published in British journal of cancer (21-09-2023)“…Background The first-in-class brain-penetrating synthetic hydroxylated lipid idroxioleic acid (2-OHOA; sodium 2-hydroxyoleate), activates sphingomyelin…”
Get full text
Journal Article -
12
Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice
Published in Gut (01-02-2014)“…No trial has compared non-bismuth quadruple 'sequential' and 'concomitant' regimens in settings with increasing clarithromycin rates. The study aims to compare…”
Get more information
Journal Article -
13
Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis
Published in Drugs (New York, N.Y.) (01-05-2017)“…Background Anti- Helicobacter pylori eradication treatment fails in a significant percentage of cases. Although this percentage has been reduced to 5–15% with…”
Get full text
Journal Article -
14
Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double‐blind, placebo‐controlled trial
Published in Helicobacter (Cambridge, Mass.) (01-10-2018)“…Objective To evaluate the safety, tolerability and efficacy of a probiotic supplementation for Helicobacter pylori (H. pylori) eradication therapy. Design…”
Get full text
Journal Article -
15
Helicobacter Pylori First-Line and Rescue Treatments in the Presence of Penicillin Allergy
Published in Digestive diseases and sciences (01-02-2015)“…Background Helicobacter pylori eradication is a challenge in penicillin allergy. Aim To assess the efficacy and safety of first-line and rescue treatments in…”
Get full text
Journal Article -
16
A quick flow cytometry protocol to assess Helicobacter pylori viability
Published in Journal of microbiological methods (01-10-2020)“…Here we present an easy flow cytometry protocol to study the viability of Helicobacter pylori which also enables the detection of even low live bacteria…”
Get full text
Journal Article -
17
Spanish primary care survey on the management of Helicobacter pylori infection and dyspepsia: Information, attitudes, and decisions
Published in Helicobacter (Cambridge, Mass.) (01-08-2019)“…Introduction Dyspepsia and Helicobacter pylori are two of the most relevant digestive conditions in primary care. Several consensuses on the subject have been…”
Get full text
Journal Article -
18
Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease
Published in Inflammatory bowel diseases (01-11-2009)“…Among the available fecal biomarkers for the diagnosis and monitoring of inflammatory bowel disease (IBD), only calprotectin and lactoferrin have translated…”
Get full text
Journal Article -
19
Warnings on the safety of quinolones: Should Helicobacter pylori treatment prescriptions be modified?
Published in Gastroenterología y hepatología (01-08-2019)Get more information
Journal Article -
20
Oral and intravenous iron treatment in inflammatory bowel disease: Hematological response and quality of life improvement
Published in Inflammatory bowel diseases (01-10-2009)“…Background: The aim was to evaluate the efficacy and tolerance of oral and intravenous iron treatment in anemic inflammatory bowel disease (IBD) patients,…”
Get full text
Journal Article